Solventum Co. (NYSE:SOLV) Receives $79.86 Consensus Target Price from Brokerages

Solventum Co. (NYSE:SOLV - Get Free Report) has received an average rating of "Hold" from the eleven ratings firms that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, nine have issued a hold recommendation and one has assigned a buy recommendation to the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $79.86.

Several equities analysts have issued reports on SOLV shares. The Goldman Sachs Group lifted their price target on shares of Solventum from $63.00 to $71.00 and gave the stock a "sell" rating in a report on Monday, March 3rd. Bank of America upped their target price on Solventum from $80.00 to $85.00 and gave the company a "neutral" rating in a research report on Wednesday, February 26th. Piper Sandler raised their price target on Solventum from $75.00 to $84.00 and gave the stock a "neutral" rating in a report on Friday, February 28th. Mizuho upped their price objective on shares of Solventum from $70.00 to $82.00 and gave the company a "neutral" rating in a report on Monday, March 3rd. Finally, Morgan Stanley lifted their target price on shares of Solventum from $73.00 to $80.00 and gave the stock an "equal weight" rating in a research note on Wednesday, March 5th.

Institutional Trading of Solventum

Hedge funds and other institutional investors have recently made changes to their positions in the business. Worldquant Millennium Advisors LLC boosted its holdings in Solventum by 373.6% in the third quarter. Worldquant Millennium Advisors LLC now owns 47,665 shares of the company's stock valued at $3,323,000 after purchasing an additional 37,600 shares during the last quarter. Harbor Capital Advisors Inc. lifted its holdings in shares of Solventum by 24.8% in the 4th quarter. Harbor Capital Advisors Inc. now owns 46,965 shares of the company's stock valued at $3,103,000 after buying an additional 9,333 shares during the period. The Manufacturers Life Insurance Company boosted its stake in shares of Solventum by 37.4% in the third quarter. The Manufacturers Life Insurance Company now owns 117,853 shares of the company's stock worth $8,217,000 after buying an additional 32,051 shares during the last quarter. State Street Corp grew its holdings in Solventum by 3.1% during the third quarter. State Street Corp now owns 6,107,550 shares of the company's stock worth $425,818,000 after acquiring an additional 185,938 shares during the period. Finally, Forsta AP Fonden purchased a new position in Solventum during the fourth quarter valued at approximately $1,876,000.

Remove Ads

Solventum Stock Down 1.0 %

Shares of Solventum stock traded down $0.73 on Wednesday, reaching $74.78. The stock had a trading volume of 1,933,229 shares, compared to its average volume of 1,475,014. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45. The stock has a market capitalization of $12.94 billion and a P/E ratio of 27.19. The company has a 50 day moving average price of $75.51 and a 200 day moving average price of $71.85. Solventum has a 1 year low of $47.16 and a 1 year high of $85.92.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.